Lipocalin-2 promotes CKD vascular calcification by aggravating VSMCs ferroptosis through NCOA4/FTH1-mediated ferritinophagy

Abstract Vascular calcification (VC) is a common complication of chronic kidney disease (CKD), for which no effective therapies are available. Hyperphosphatemia, a feature of CKD, is a well-known inducer of VC. High phosphate (HP)-induced ferroptosis plays a crucial role in CKD-related VC (CKD-VC),...

Full description

Saved in:
Bibliographic Details
Main Authors: Yujia Wang, Yuxia Zhang, Min Gao, Zhiqing Chen, Jing Lu, Yongqi Li, Yan Di, Yinan Zhao, Bicheng Liu, Rining Tang
Format: Article
Language:English
Published: Nature Publishing Group 2024-11-01
Series:Cell Death and Disease
Online Access:https://doi.org/10.1038/s41419-024-07260-x
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846147354393051136
author Yujia Wang
Yuxia Zhang
Min Gao
Zhiqing Chen
Jing Lu
Yongqi Li
Yan Di
Yinan Zhao
Bicheng Liu
Rining Tang
author_facet Yujia Wang
Yuxia Zhang
Min Gao
Zhiqing Chen
Jing Lu
Yongqi Li
Yan Di
Yinan Zhao
Bicheng Liu
Rining Tang
author_sort Yujia Wang
collection DOAJ
description Abstract Vascular calcification (VC) is a common complication of chronic kidney disease (CKD), for which no effective therapies are available. Hyperphosphatemia, a feature of CKD, is a well-known inducer of VC. High phosphate (HP)-induced ferroptosis plays a crucial role in CKD-related VC (CKD-VC), but the mechanisms remain unclear. Lipocalin-2 (LCN2), an iron-trafficking protein, has been implicated in ferroptosis regulation. In the present study, the role of LCN2 as a potential mediator of CKD-VC was investigated. HP-induced LCN2 expression in the arteries of CKD-VC patients, animal models and vascular smooth muscle cells (VSMCs). LCN2 knockout (LCN2KO) mice and wild-type (WT) mice fed with a high adenine and phosphate (AP) diet were studied to explore CKD-VC. Compared with WT mice, LCN2KO mice showed an amelioration of the CKD-VC induced by the AP diet. The inhibition of LCN2 also alleviated HP-induced calcium deposition and phenotypic transition in VSMCs. Conversely, VSMCs-targeted LCN2 overexpression or recombinant LCN2 treatment exacerbated CKD-VC in vivo and in vitro. Mechanistically, nuclear receptor coactivator 4 (NCOA4)/ferritin heavy chain 1 (FTH1)-mediated ferritinophagy-dependent ferroptosis was involved in LCN2-mediated CKD-VC. Under HP conditions, LCN2 interacted with NCOA4, potentially accelerating the degradation of FTH1 and inducing ferroptosis. The inhibition of LCN2 may rescue the degradation of FTH1 and thus ameliorate ferroptosis, significantly suppressing VSMCs calcification. In summary, our study revealed a novel role for LCN2 induced ferritinophagy-dependent ferroptosis in CKD-VC, and targeting LCN2 might be a promising treatment for CKD-VC.
format Article
id doaj-art-6f90fb6ad7da44d7a6f882fbd95ff9de
institution Kabale University
issn 2041-4889
language English
publishDate 2024-11-01
publisher Nature Publishing Group
record_format Article
series Cell Death and Disease
spelling doaj-art-6f90fb6ad7da44d7a6f882fbd95ff9de2024-12-01T12:47:26ZengNature Publishing GroupCell Death and Disease2041-48892024-11-01151111810.1038/s41419-024-07260-xLipocalin-2 promotes CKD vascular calcification by aggravating VSMCs ferroptosis through NCOA4/FTH1-mediated ferritinophagyYujia Wang0Yuxia Zhang1Min Gao2Zhiqing Chen3Jing Lu4Yongqi Li5Yan Di6Yinan Zhao7Bicheng Liu8Rining Tang9Institute of Nephrology, Zhongda Hospital, School of Medicine, Southeast UniversityInstitute of Nephrology, Zhongda Hospital, School of Medicine, Southeast UniversityInstitute of Nephrology, Zhongda Hospital, School of Medicine, Southeast UniversityInstitute of Nephrology, Zhongda Hospital, School of Medicine, Southeast UniversityInstitute of Nephrology, Zhongda Hospital, School of Medicine, Southeast UniversityInstitute of Nephrology, Zhongda Hospital, School of Medicine, Southeast UniversityInstitute of Nephrology, Zhongda Hospital, School of Medicine, Southeast UniversityInstitute of Nephrology, Zhongda Hospital, School of Medicine, Southeast UniversityInstitute of Nephrology, Zhongda Hospital, School of Medicine, Southeast UniversityInstitute of Nephrology, Zhongda Hospital, School of Medicine, Southeast UniversityAbstract Vascular calcification (VC) is a common complication of chronic kidney disease (CKD), for which no effective therapies are available. Hyperphosphatemia, a feature of CKD, is a well-known inducer of VC. High phosphate (HP)-induced ferroptosis plays a crucial role in CKD-related VC (CKD-VC), but the mechanisms remain unclear. Lipocalin-2 (LCN2), an iron-trafficking protein, has been implicated in ferroptosis regulation. In the present study, the role of LCN2 as a potential mediator of CKD-VC was investigated. HP-induced LCN2 expression in the arteries of CKD-VC patients, animal models and vascular smooth muscle cells (VSMCs). LCN2 knockout (LCN2KO) mice and wild-type (WT) mice fed with a high adenine and phosphate (AP) diet were studied to explore CKD-VC. Compared with WT mice, LCN2KO mice showed an amelioration of the CKD-VC induced by the AP diet. The inhibition of LCN2 also alleviated HP-induced calcium deposition and phenotypic transition in VSMCs. Conversely, VSMCs-targeted LCN2 overexpression or recombinant LCN2 treatment exacerbated CKD-VC in vivo and in vitro. Mechanistically, nuclear receptor coactivator 4 (NCOA4)/ferritin heavy chain 1 (FTH1)-mediated ferritinophagy-dependent ferroptosis was involved in LCN2-mediated CKD-VC. Under HP conditions, LCN2 interacted with NCOA4, potentially accelerating the degradation of FTH1 and inducing ferroptosis. The inhibition of LCN2 may rescue the degradation of FTH1 and thus ameliorate ferroptosis, significantly suppressing VSMCs calcification. In summary, our study revealed a novel role for LCN2 induced ferritinophagy-dependent ferroptosis in CKD-VC, and targeting LCN2 might be a promising treatment for CKD-VC.https://doi.org/10.1038/s41419-024-07260-x
spellingShingle Yujia Wang
Yuxia Zhang
Min Gao
Zhiqing Chen
Jing Lu
Yongqi Li
Yan Di
Yinan Zhao
Bicheng Liu
Rining Tang
Lipocalin-2 promotes CKD vascular calcification by aggravating VSMCs ferroptosis through NCOA4/FTH1-mediated ferritinophagy
Cell Death and Disease
title Lipocalin-2 promotes CKD vascular calcification by aggravating VSMCs ferroptosis through NCOA4/FTH1-mediated ferritinophagy
title_full Lipocalin-2 promotes CKD vascular calcification by aggravating VSMCs ferroptosis through NCOA4/FTH1-mediated ferritinophagy
title_fullStr Lipocalin-2 promotes CKD vascular calcification by aggravating VSMCs ferroptosis through NCOA4/FTH1-mediated ferritinophagy
title_full_unstemmed Lipocalin-2 promotes CKD vascular calcification by aggravating VSMCs ferroptosis through NCOA4/FTH1-mediated ferritinophagy
title_short Lipocalin-2 promotes CKD vascular calcification by aggravating VSMCs ferroptosis through NCOA4/FTH1-mediated ferritinophagy
title_sort lipocalin 2 promotes ckd vascular calcification by aggravating vsmcs ferroptosis through ncoa4 fth1 mediated ferritinophagy
url https://doi.org/10.1038/s41419-024-07260-x
work_keys_str_mv AT yujiawang lipocalin2promotesckdvascularcalcificationbyaggravatingvsmcsferroptosisthroughncoa4fth1mediatedferritinophagy
AT yuxiazhang lipocalin2promotesckdvascularcalcificationbyaggravatingvsmcsferroptosisthroughncoa4fth1mediatedferritinophagy
AT mingao lipocalin2promotesckdvascularcalcificationbyaggravatingvsmcsferroptosisthroughncoa4fth1mediatedferritinophagy
AT zhiqingchen lipocalin2promotesckdvascularcalcificationbyaggravatingvsmcsferroptosisthroughncoa4fth1mediatedferritinophagy
AT jinglu lipocalin2promotesckdvascularcalcificationbyaggravatingvsmcsferroptosisthroughncoa4fth1mediatedferritinophagy
AT yongqili lipocalin2promotesckdvascularcalcificationbyaggravatingvsmcsferroptosisthroughncoa4fth1mediatedferritinophagy
AT yandi lipocalin2promotesckdvascularcalcificationbyaggravatingvsmcsferroptosisthroughncoa4fth1mediatedferritinophagy
AT yinanzhao lipocalin2promotesckdvascularcalcificationbyaggravatingvsmcsferroptosisthroughncoa4fth1mediatedferritinophagy
AT bichengliu lipocalin2promotesckdvascularcalcificationbyaggravatingvsmcsferroptosisthroughncoa4fth1mediatedferritinophagy
AT riningtang lipocalin2promotesckdvascularcalcificationbyaggravatingvsmcsferroptosisthroughncoa4fth1mediatedferritinophagy